Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, 3-Way Crossover Study To Determine The Effects Of Single Inhaled Doses Of PF-03715455 (20 Mg) And PH-797804 (30 Mg) On Induced Sputum Neutrophils Following Inhaled Lipopolysaccharide (LPS) Challenge In Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2015
At a glance
- Drugs PF 3715455 (Primary) ; PH 797804 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Biomarker; Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 01 Feb 2012 Actual end date (1 Dec 2011) added as reported by ClinicalTrials.gov.
- 01 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov